Final result of the rights offering

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG OR JAPAN OR SUCH OTHER JURISDICTIONS WHERE THE OFFERING AND SALE OF THE NEW SHARES AND THE SUBSCRIPTION RIGHTS IS RESTRICTED BY LAW.

DiaGenic ASA

Reference is made to the stock exchange announcement made by Diagenic ASA (the "Company") on 1 April 2014 regarding the rights issue (the "Rights Offering"). The allocation from the Rights Offering, which closed on 31 March 2014 at 17:30, was concluded by the Board of DiaGenic ASA on 4 April 2014.

After the close of the subscription period a total of 100,000,000 offered shares (the "Offered Shares") at NOK 0.50 per share have been allocated. It was subscribed for a total of 238,556,562 shares. The Rights Offering was underwritten by a consortium of existing shareholders including Alfred Berg, Arkipel, MP Pensjon, Spar Kapital Investor, Storebrand Vekst, Corona Maritime, Gross Management, and Ferncliff Listed DAI (the "Underwriters"). As the Rights Offering was oversubscribed, no shares have been allocated to the Underwriter in its capacity as an underwriter, as set forth in the allocation procedure described in the prospectus dated 14 March 2014.

Approximately 87 per cent (approximately 87.3 million shares) of the Offered Shares, were subscribed for by utilising subscription rights. Approximately 151 per cent (approximately 151.2 million shares) of the Offered Shares were oversubscribed or subscribed for without subscription rights.

Based on the allocation principles described in the prospectus dated 14 March 2014, approximately 87.3 million new shares were allocated to subscribers according to held subscription rights, and approximately 12.7 million new shares were allocated to holders of subscription rights that oversubscribed. No allocation was made to subscribers without subscription rights.

Through the rights offering DiaGenic ASA will receive proceeds amounting to approximately NOK 50 million.

Notice of allocation and payment instructions will be sent out on 4 April 2014. Payment date will be 8 April 2014 and all subscribers being allotted offered shares must ensure that sufficient funds are available in the bank account stated in the subscription form within 7 April 2014. The share capital increase pertaining to the Offered Shares will be registered with the Norwegian Register of Business Enterprises (Foretaksregisteret) as soon as payment of the entire proceeds for the Offered Shares has been received by the Company. The Offered Shares allocated to subscribers in the Rights Offering will thereafter be distributed to the subscribers’ VPS accounts. Completion of the Rights Offering and registration and listing of the Offered Shares is expected on or about 10 April 2014.

On completion of the rights offering, DiaGenic ASA will issue 100,000,000 new shares with a nominal value of NOK 0.20, increasing its share capital by NOK 20,000,000 to NOK 21,631,974.60, corresponding to a total of 108,159,873 shares with a nominal value of NOK 0.20 per share.

The new shares may not be transferred or traded before they are fully paid and the share capital increase has been registered with the Norwegian Register of Business Enterprises and the new shares registered in the VPS.

The Rights Offering is managed by Arctic Securities ASA.

For further information, please contact:

Lars Christian Stugaard, Interim CEO, DiaGenic ASA, tel +47 23 01 49 06

This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)